Hepatocellular Cancer Video Channel
Explore the latest insights and summaries from experts in Hepatocellular Cancer.
Recommended for You
Loading...
Trending Videos This Week
Loading...
Treatment Landscape
COR2ED The Heart of Medical Education
Advanced HCC: When to Switch to 2L Treatment - Case Presentation
FEATURING
Timon Vandamme
- 97 views
- April 19, 2024
- 1
Yale Cancer Center
Updates in Combination Therapy for HCC
FEATURING
Stacey Stein
- 457 views
- April 24, 2024
Johns Hopkins
Current Evidence for Frontline Systematic Treatment in Advanced HCC
FEATURING
Marina Baretti
- 274 views
- May 29, 2024
Johns Hopkins
[duplicate] Current Evidence for Frontline Systematic Treatment in Advanced HCC
FEATURING
Marina Baretti
- 1 view
- May 29, 2024
Yale Cancer Center
New Guidelines in the Management of Liver Cancer
FEATURING
Tamar Taddei
- 58 views
- May 29, 2024
Yale Cancer Center
[duplicate] New Guidelines in the Management of Liver Cancer
FEATURING
Tamar Taddei
- May 29, 2024
Stanford Medicine
Hepatocellular Carcinoma: Current Management Strategies
FEATURING
Renumathy Dhanasekaran
- 240 views
- June 1, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "HCC Highlights From the CheckMate 9DW and CARES-310 Studies"
FEATURING
Arndt Vogel
- 221 views
- June 25, 2024
- 2
Insights from 2024 ESMO GI Annual Meeting
ESMO GI 2024 Insights: Ten Years of Improvement in the Treatment of Liver Cancer
FEATURING
Stephen L. Chan
- 142 views
- July 16, 2024
- 1
Lionel Kankeu Fonkoua
Current Approach to Frontline Systemic Therapy for Advanced Hepatocellular Carcinoma
- 266 views
- July 16, 2024
- 2
Nebraska Oncology Society
Recent Updates in the Treatment Landscape for Advanced HCC
FEATURING
Rachael Safyan
- 50 views
- August 13, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Selecting 1L Therapy and Sequencing After Immunotherapy in Unresectable HCC
FEATURING
Lorenza Rimassa
- 404 views
- September 20, 2024
- 5
Keck School of Medicine of USC
Old and New: Treatment Updates for Early-Stage Hepatocellular Carcinoma
FEATURING
Kali Zhou
- 42 views
- September 25, 2024
Integrity CE
Choosing the Best HCC Treatment Based on Patient and Disease Stage
- 131 views
- October 1, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Optimizing Curative Opportunities in Early HCC
FEATURING
Stephen L. Chan
- 109 views
- October 2, 2024
- 2
Houston Methodist
Management of Hepatocellular Carcinoma & Cholangiocarcinoma - Role of Immunotherapy & Ablative Therapies
FEATURING
Ahmed O. Kaseb
- 43 views
- October 3, 2024
Integrity CE
Expert Panel on TACE and TARE for HCC: Weighing the Pros and Cons
FEATURING
Michael Pishvaian,
Riad Salem
- 98 views
- October 8, 2024
- 1
Integrity CE
Expert Panel on Choosing Systemic vs. Locoregional Therapy in HCC
- 46 views
- October 8, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Updates in HCC and Impacts on Practice
FEATURING
Hani Babiker
- 170 views
- October 14, 2024
- 1
Angelo Pirozzi
Optimizing Therapy Selection for Frontline Treatment of Advanced HCC
- 89 views
- October 16, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Highlights in HCC
FEATURING
Richard Kim,
Tiago Biachi
- 223 views
- October 21, 2024
- 3
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: CheckMate 9DW Expanded Analysis - Nivo + Ipi vs. Len or Sorafenib in 1L Unresectable HCC
FEATURING
Hatim Karachiwala
- 136 views
- October 21, 2024
- 2
COR2ED The Heart of Medical Education
ESMO 2024 Summary: HCC Treatment Highlights
FEATURING
Richard S. Finn
- 42 views
- November 1, 2024
- 1
ecancer
Selecting Patients Wisely for Neoadjuvant Therapy in Pancreatic and Hepatobiliary Cancers
FEATURING
Shailesh Shrikhande
- 31 views
- November 10, 2024
Integrity CE
The Role of Adjuvant Therapy Following HCC Resection
FEATURING
Marina Baretti
- 222 views
- March 27, 2024
- 2
Yale Cancer Center
Evolving Surgical Strategies in HCC
FEATURING
Kevin Billingsley
- 174 views
- April 24, 2024
Northwestern Medicine Gastroenterology
Hepato-Oncology: Highlights from AASLD 2024
FEATURING
Laura Kulik
- 11 views
- December 8, 2024
Therapeutic Agents
Cedars Sinai
Management of Toxicity and Dose Modification Associated With Cabozantinib in HCC
FEATURING
Jun Gong
- 265 views
- April 19, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "HCC Highlights From the CheckMate 9DW and CARES-310 Studies"
FEATURING
Arndt Vogel
- 221 views
- June 25, 2024
- 2
Nebraska Oncology Society
Recent Updates in the Treatment Landscape for Advanced HCC
FEATURING
Rachael Safyan
- 50 views
- August 13, 2024
Exelixis
Hypothetical Patient Case: Hepatocellular Carcinoma with Progression from Child-Pugh A to Child-Pugh B Liver Function
FEATURING
Julio Gutierrez,
Joshua Strauss
- 119 views
- November 11, 2024
Exelixis
Hypothetical Patient Case: Hepatocellular Carcinoma and Considerations for 2L Treatment Post Sorafenib
FEATURING
Julio Gutierrez,
Joshua Strauss
- 77 views
- November 11, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: HIMALAYA - 5-Year OS of Tremelimumab + Durvalumab in Unresectable HCC
FEATURING
Lorenza Rimassa
- 173 views
- September 20, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: TACE ± Lenvatinib + Pembro for Int-Stage HCC - Ph3 LEAP-012 Study
FEATURING
Josep Llovet
- 210 views
- September 23, 2024
- 3
Houston Methodist
Management of Hepatocellular Carcinoma & Cholangiocarcinoma - Role of Immunotherapy & Ablative Therapies
FEATURING
Ahmed O. Kaseb
- 43 views
- October 3, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: CheckMate 9DW Expanded Analysis - Nivo + Ipi vs. Len or Sorafenib in 1L Unresectable HCC
FEATURING
Hatim Karachiwala
- 136 views
- October 21, 2024
- 2
UCLA Health
Y90 Radioembolization for Locally Advanced HCC
FEATURING
Siddharth Padia
- 650 views
- March 1, 2024
- 4
Johns Hopkins
Impact of Neoadjuvant IO on Recurrence-Free Survival in High-Risk Localized HCC
FEATURING
Mari Nakazawa
- 97 views
- November 7, 2024
Diagnostics & Biomarkers
Florida Gastroenterologic Society
Practical Approach to Cystic & Solid Liver Lesions: When to Worry
FEATURING
Anjuli Luthra
- 451 views
- September 12, 2024
- 5
Indiana University School of Medicine Division of Gastroenterology and Hepatology
Liver Lesions
FEATURING
John Holden
- 40 views
- October 30, 2024
Flavio Rocha
How to Incorporate Molecular Testing in Therapy for Localized Cholangiocarcinoma
- 198 views
- March 18, 2024
Disease Overview
Yale Cancer Center
Understanding HCC: Perspectives on Diagnosis, Risk Factors, and Treatment
FEATURING
Ariel Jaffe
- 336 views
- April 24, 2024
- 1
Yale Cancer Center
New Guidelines in the Management of Liver Cancer
FEATURING
Tamar Taddei
- 58 views
- May 29, 2024
Yale Cancer Center
[duplicate] New Guidelines in the Management of Liver Cancer
FEATURING
Tamar Taddei
- May 29, 2024
Yale Cancer Center
The Importance of a Multidisciplinary Approach to Liver Cancer Care
FEATURING
Tamar Taddei,
Eric Winer
- 49 views
- September 4, 2024
Houston Methodist
Evolving Epidemiology of Hepatocellular Cancer & Cholangiocarcinoma
FEATURING
Ashton Connor
- 20 views
- October 3, 2024
Case Studies
COR2ED The Heart of Medical Education
Advanced HCC: When to Switch to 2L Treatment - Case Presentation
FEATURING
Timon Vandamme
- 97 views
- April 19, 2024
- 1
COR2ED The Heart of Medical Education
Advanced HCC: Treatment Options for Patients Ineligible for IO - Case Presentation
FEATURING
Sammy Saab
- 48 views
- April 19, 2024
University of Miami
HCC Case-Based Panel Discussion
FEATURING
Melissa Franco
- 25 views
- April 12, 2024
Exelixis
Hypothetical Patient Case: Hepatocellular Carcinoma with Progression from Child-Pugh A to Child-Pugh B Liver Function
FEATURING
Julio Gutierrez,
Joshua Strauss
- 119 views
- November 11, 2024
Exelixis
Hypothetical Patient Case: Hepatocellular Carcinoma and Considerations for 2L Treatment Post Sorafenib
FEATURING
Julio Gutierrez,
Joshua Strauss
- 77 views
- November 11, 2024
Houston Methodist
Liver Transplantation for Hepatocellular Cancer & Cholangiocarcinoma – Current Approach & Controversies
FEATURING
Sudha Kodali
- 30 views
- October 3, 2024
COR2ED The Heart of Medical Education
Advanced HCC Case Discussion: Treatment Options for Patients With Autoimmune Disorders
FEATURING
Sammy Saab
- 29 views
- October 6, 2024
Integrity CE
Intermediate Stage HCC With a Hx of Cirrhosis: Case Presentation and Panel Discussion
- 52 views
- March 27, 2024
Integrity CE
Intermediate Stage HCC With No Hx of Cirrhosis: Case Presentation and Panel Discussion - 2
- 84 views
- March 27, 2024
- 1